Press Coverage

BeiGene Falls After Ending Drug Licensing Deal With Novartis

Excerpt:“…ended little changed SMARTKARMA (Xinyao (Criss) Wang) “Our understanding of Novartis’ decision to abandon TIGIT…”

BFW (Bloomberg First Word)via Bloomberg • (Opens in a new window) ⧉

Are you a Professional Journalist?

The Smartkarma Press Pass is a special login created exclusively for pre-approved professional journalists. It allows a journalist to access content on the platform and use all the powerful search and discovery functionality available. Journalists can excerpt and quote from the content on Smartkarma to enrich and support their articles.


Request your Press Pass Now

BFW (Bloomberg First Word)